Lymphocyte blast transformation and interferon production in mononuclear cell cultures prepared on Ficoll-Hypaque gradients from individuals with herpes simplex virus-I infection were enhanced by a disease recurrence. Responses to both herpes simplex virus-2 and phytohemagglutinin were unaltered. Transformation to herpes simplex virus-i antigen was adversely affected by depleting either thymus-derived (T) lymphocytes or bone marrow-derived (B) lymphocytes to- In humans, cellular immunity to HSV has been studied by using different in vitro variables, most commonly, lymphocyte transformation. The significance of lymphocyte transformation as a correlate of susceptibility to recurrent HSV infection is not established. Defects in transformation to HSV antigen associated with acute disease have been detected by some investigators (6), but not by others (7-11). Defects in lymphokine production in vitro, for example, in migration inhibiting factor and interferon production have been reported during acute HSV infection (7, 12) . In cardiac transplant recipients, low responses of lymphocyte interferon production and transformation to HSV antigen are associated with both severe and prolonged HSV infection (13).
non-rosetting cell, probably a monocyte. Depletion of B lymphocytes and monocytes, but not of Tlymphocytes, resulted in reduction in interferon production. Irradiated B lymphocytes and monocytes failed to produce significant quantities of interferon, suggesting that a radiosensitive B cell was a major interferon source. There is evidence for the importance of cellular immunity in limiting herpesvirus infections. Adoptive transfer of spleen cells from mice immunized with herpes simplex virus (HSV) protected syngeneic irradiated mice against lethal challenge with the virus (1, 2) . Treatment of mice with anti-lymphoid sera (3) (4) (5) potentiates HSV infection, pointing to a role for sensitized lymphoid cells in host defense.
In humans, cellular immunity to HSV has been studied by using different in vitro variables, most commonly, lymphocyte transformation. The significance of lymphocyte transformation as a correlate of susceptibility to recurrent HSV infection is not established. Defects in transformation to HSV antigen associated with acute disease have been detected by some investigators (6), but not by others (7) (8) (9) (10) (11) . Defects in lymphokine production in vitro, for example, in migration inhibiting factor and interferon production have been reported during acute HSV infection (7, 12) . In cardiac transplant recipients, low responses of lymphocyte interferon production and transformation to HSV antigen are associated with both severe and prolonged HSV infection (13) .
It is important to measure responses of thymus-derived (T) lymphocytes to specific antigens in cellular immune reactions. There are observations that viral antigens stimulate the incorporation of [3H] thymidine in B as well as T lymphocytes (14) (15) (16) . This indicates that transformation may not correlate only with T cell function. The production of lymphokines is also complex. Various immunocytes yield soluble factors such as migration inhibiting factor (17), mitogenic factor (18), lymphotoxin (19) , and interferon (20, 21) , raising doubts about the validity of measuring lymphokines as indicators of T cell function. Mitogens. Lyophilized phytohemagglutinin-P (PHA) (Difco, Detroit, MI) was reconstituted in 5 ml of phosphate buffered saline and diluted 1:30. Pokeweed mitogen (PWM) (Gibco, Grand Island, NY) was reconstituted in 10 ml of the buffered saline and diluted 1:60. Mononuclear Cell Cultures. The microculture assay for lymphocyte transformation and interferon production from cells separated on Ficoll/Hypaque (FH) gradients has been described (22) . T lymphocytes were purified on nylon fiber columns (23) . The eluate was centrifuged on a FH gradient. T lymphocytes so prepared gave at least 60% rosette formation with papain-treated sheep erythrocytes (24) , and at least 95% were killed by anti-human T lymphocyte sera (25) .
Bone marrow-derived (B) lymphocyte-enriched populations were obtained by incubating 5 X 106 mononuclear cells per ml with 0.5% papain-treated sheep erythrocytes in 50% fetal calf serum for 15 min at room temperature. The mixture was centrifuged at 200 X g for 5 min and held for 1.5 hr at room temperature. After gently resuspending the cell pellet and centrifuging at 400 X g for 30 min on a FH gradient, the nonrosetted cells at the interface of the FH and medium had residual rosette-forming cells of less than 5% and, for most experiments, less than 1%. Of the nonrosetted cells, 10-70% had surface immunoglobulins and 10-40% were monocytes.
For monocyte depletion, leukocytes from dextran-sedimented, heparinized blood were centrifuged at 200 X g, resuspended in 30 ml McCoy's 5A medium, and incubated for Abbreviations: T, thymus-derived; B, bone marrow-derived; HSV, herpes simplex virus; PHA, phytohemagglutinin P; PWM, pokeweed mitogen; FH, Ficoll-Hypaque. 3957 The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
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Medical Sciences: Rasmussen and Merigan 20 min at 370 with 25 mg iron carbonyl powder (GAF Corporation, New York, NY). Cells with ingested iron carbonyl particles were removed with a magnetic bar. The remaining cells, when centrifuged on FH gradients had less than 1% monocytes. For some experiments, after monocyte removal, cells were subsequently depleted of T lymphocytes.
T lymphocytes were quantitated by mixing 1 X 106 cells in 0.1 ml with 0.1 ml of 0.5% papain-treated sheep erythrocytes, centrifuging for 5 min at 200 X g, and incubating the mixture at room temperature for 1.5 hr. By using a hemacytometer, mononuclear cells with three or more attached sheep erythrocytes were scored as positive for rosette formation. B lymphocytes were quantitated by using direct immunofluorescent staining of surface immunoglobulins (25) . Monocytes were identified by cytoplasmic esterase staining (26) .
Study Population. All donors were healthy adults who were diagnosed at the time of lesion recurrence by either isolation of virus or detection of cells with HSV-1 antigen by immunofluorescence with monospecific rabbit anti-HSV-1 sera.
RESULTS

Effect of Recurrent Infection on Lymphocyte
Responses to HSV Antigen. Fig. 1 shows the kinetics of (A) lymphocyte transformation and (B) interferon production by cells from individuals at different times after HSV-1 recurrence. Statistically significant differences (P < .005) in mean transformation indices were detected by comparing the following groups: (i) those with no detectable antibody (no complement fixation at 1:4 dilution) with all groups with history of infection and (H) (27) . For interferon (Fig. 3, upper) (Fig. 4, lower left) (28, 29 1 hr at room temperature with sufficient antisera to human leukocyte type I interferon to neutralize 100 units of antiviral activity. The antiviral activity in supernatants from both T cells and B cells with monocytes was reduced by at least 60% after incubation with antisera to type I interferon (30) indicating that the interferon was Type I rather than immune (Type II). to those of murine splenic lymphocytes. Additionally, infectious virus used for stimulation of the murine cells may initiate cellular responses distinct from those of the inactivated virus used in our studies in humans.
The monocyte-dependent T lymphocyte transformation with HSV antigen is consistent with those of other investigators who used nonspecific mitogens and other viral antigens (33) (34) (35) (36) as well as with our earlier studies that showed enhanced transformation by T cells with monocyte-derived macrophages (23) . Since supernatants from mononuclear cells stimulated with HSV antigen were ineffective in promoting T cell proliferation, the mechanism by which the monocyte enhances transformation probably requires cell-to-cell contact rather than soluble mediators (37, 38) . Soluble antigens can be concentrated by monocytes to give a more potent stimulus to lymphocytes (39) .
No obvious defect in T lymphocyte transformation was associated with recurrence of HSV infection. Instead, the disease episode increased the T lymphocyte response to HSV-1 antigen, as shown in other studies (7) (8) (9) (10) . The enhanced T cell response during recurrent disease may reflect the activity of cells in immunologically normal individuals which are more important in restricting the disease to a local site as suggested by Russell (40) rather than governing the frequency of recurrences.
Whether the T lymphocyte that is transformed has a direct effector function for limiting virus infection remains to be determined. Effector functions in some murine virus infections have been attributed to histocompatibility restricted cytotoxic T lymphocytes present in spleens (41, 42) . However, in humans it has not been possible to demonstrate cytotoxic effector cells in the peripheral blood of individuals immunized with vaccinia (43) despite the presence of T lymphocytes that transform in response to vaccinia virus antigen (44) . In model systems using HSV infected mice (45) and rabbits (46) , cytotoxic T lympho- Proc. Natl. Acad. Sci. USA 75 (1978) Proc. Natl. Acad. Sci. USA 75 (1978) 3961 cytes could be demonstrated only at local sites. These studies imply that the proliferating cells in the peripheral blood of humans may represent a precursor which could give rise to effector cells that are sequestered locally.
The reduction in interferon production after irradiation of B lymphocytes and monocytes indicates that viable B cells are a major source for interferon production. Most monocyte functions are radioresistant; therefore, this cell most likely contributes to interferon in a helper capacity. In addition, we have been unable to detect significant interferon production in cultures of glass adherent cells, mostly monocytes, after stimulation with HSV antigen (data not shown). Finally, the amount of interferon produced in supernatants was proportional to the increases in the number of non-T lymphocytes.
The B lymphocyte responds to HSV antigen with interferon production under at least two circumstances. During acute recurrent HSV-1 disease, interferon production is in part immune specific since the increased response occurs only after stimulation with HSV-1 antigen. In nonimmune individuals-i.e., those with no detectable T lymphocyte transformation and minimal production of interferon by T lymphocytes (22)-the interferon detected in mononuclear cultures from FH gradients is most likely of B cell origin. This finding suggests that the B cell may be particularly responsive to interferon induction even without immune sensitization, as is the case for Sendai virus-induced interferon from human B cells (47) .
The physicochemical type and immune nature of interferons may relate to the cell of origin. Type II interferon from T lymphocytes with macrophages is immune specific and may be quantitatively related to HSV lesion frequency (23, 30) . Type I interferon from T lymphocytes alone is also immune specific (22) . These studies show that the B lymphocyte yields more type I interferon than T lymphocytes and its production is unrelated to the presence of sensitized T lymphocytes. Interferon is important in resolution of HSV infection (48, 49) . Whether or not a single type is critical in host defense is a subject for future investigation.
